Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
Go back to Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform| (NASDAQ: RXRX) | Delayed: 3.17 -0.01 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $ | |||
| Open | $3.10 | 52 Week Low | $ | |||
| Day High | $3.27 | P/E | N/A | |||
| Day Low | $3.09 | EPS | $ | |||
| Volume | 4,307,757 | |||||
| (NASDAQ: RXRX) | Delayed: 3.17 -0.01 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $ | |||
| Open | $3.10 | 52 Week Low | $ | |||
| Day High | $3.27 | P/E | N/A | |||
| Day Low | $3.09 | EPS | $ | |||
| Volume | 4,307,757 | |||||

